MedPath

Impact of Slowly Digestible Carbohydrates on the Gut-brain Axis

Not Applicable
Completed
Conditions
Appetitive Behavior
Obesity
Diabetes Mellitus, Type 2
Interventions
Other: Rice flour
Other: Alternanoligosaccharide 15
Other: Inulin
Other: Waxy potato starch
Other: Waxy potato starch + epigallocatechin gallate (EGCG)
Other: Chickpea flour + epigallocatechin gallate (EGCG)
Registration Number
NCT05349903
Lead Sponsor
Purdue University
Brief Summary

Our laboratory is investigating the physiological outcomes and health benefits of the consumption of high-quality carbohydrates. One important aspect of the high-quality carbohydrate characteristics is a slow and sustained digestion and glucose release to the blood. In the proposed study, the investigators will evaluate the consumption of different types of slowly digestible carbohydrates (SDCs) and their beneficial effects including moderation of the glycemic response profile (postprandial glycemic response, PPGR) and stimulation of the gut-brain axis, which controls appetite and food intake. This stimulation will be evaluated in terms of second-meal food intake and the circulatory level of appetite-suppressing gut hormones (such as glucagon-like peptide-1).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • BMI 18.5 - 25 kg/m2
  • Stable weight for the past 3 months (i.e. +/- 2..5 kg)
Exclusion Criteria
  • Pregnant or nursing women
  • Diabetic
  • Individuals with history of gastrointestinal disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Rice flourRice flourRapidly digestible control
Alternanoligosaccharide 15Alternanoligosaccharide 15-
InulinInulin-
Waxy potato starchWaxy potato starch-
Combination of waxy potato starch and epigallocatechin gallate (EGCG)Waxy potato starch + epigallocatechin gallate (EGCG)-
Combination of chickpea flour and epigallocatechin gallate (EGCG)Chickpea flour + epigallocatechin gallate (EGCG)-
Primary Outcome Measures
NameTimeMethod
Postprandial glycemic responseAcute study: [4 hours of measurement after consumption of test food]

Blood plasma glucose will be measured, (t max)

Postprandial plasma gut hormone responseAcute study: [4 hours of measurement after consumption of test food]

Blood plasma glucagon-like peptide-1 and insulin will be measured, (t max)

Secondary Outcome Measures
NameTimeMethod
Gastric emptying rateAcute study: 4 hours of measurement after consumption of test food]

Breath test will be performed using 13C-acetate mixed into test meals

Appetite ratings (Visual Analog Scale, VAS)Acute study: [4 hours of measurement after consumption of test food]

Hunger and fullness scores will be measured using a 10-cm scale (0 = weakest feeling of hunger or fullness and 10 = strongest feeling of hunger or fullness) after consumption of test food. Weaker feelings of hunger and stronger feelings of fullness indicate better outcomes.

Food Intake of the next mealAcute study: After the consumption a second meal [4 hours later after consuming the first meal]

At the end of the 4 hour window, participants will be given a large second meal for consumption and the amount of consumed food (food intake) will be estimated.

Breath hydrogen (fermentability)Acute study: [4 hours of measurement after consumption of test food]

Breath samples will be collected in 15-minute intervals for 4 hours after consumption of test food and analyzed for hydrogen levels using a breath analyzer. Breath hydrogen levels are indicative of a food's fermentability.

Trial Locations

Locations (1)

Purdue University

🇺🇸

West Lafayette, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath